Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Site

Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.

140 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Site trial results

Completed

Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]

NCT03555422

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Florida Cancer Specialists (Sarah Cannon Research Institute) West Palm Beach, Florida, United States
View all 78 locations
View Trial Details
Completed

An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

NCT01968109

Conditions
Neoplasms, Neoplasms by Site
Locations
  • Local Institution - 0043 La Jolla, California, United States
  • Local Institution - 0053 Aurora, Colorado, United States
  • Local Institution - 0058 Tampa, Florida, United States
  • Local Institution - 0003 Chicago, Illinois, United States
View all 54 locations
View Trial Details
Completed

Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies

NCT05054725

Conditions
Bronchial Diseases, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • BRCR Medical Center Inc. Plantation, Florida, United States
  • Cancer Specialists of North Florida Saint Augustine, Florida, United States
  • GenHarp Clinical Solutions Evergreen Park, Illinois, United States
View all 60 locations
View Trial Details
Completed

A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

NCT03656718

Conditions
Neoplasms, Neoplasms by Site
Locations
  • Winship Cancer Institute. Atlanta, Georgia, United States
  • Local Institution - 0024 Rockville, Maryland, United States
  • Local Institution - 0020 Detroit, Michigan, United States
  • Local Institution - 0001 Charlotte, North Carolina, United States
View all 36 locations
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

NCT04774952

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +63 more
Locations
  • UC Irvine - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions